Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback